Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
581K
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
38.7K
-
Shares change
-
+38.3K
-
Total reported value, excl. options
-
$145K
-
Value change
-
+$144K
-
Number of buys
-
13
-
Price
-
$3.76
Significant Holders of SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (SEELQ) as of Q3 2024
14 filings reported holding SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q3 2024.
SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (SEELQ) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.7K shares
of 581K outstanding shares and own 6.66% of the company stock.
Largest 10 shareholders include AdvisorShares Investments LLC (18.1K shares), Modera Wealth Management, LLC (10.8K shares), UBS Group AG (8.48K shares), MORGAN STANLEY (675 shares), BlackRock, Inc. (354 shares), Tower Research Capital LLC (TRC) (95 shares), Carmichael Hill & Associates, Inc. (62 shares), BANK OF AMERICA CORP /DE/ (32 shares), JPMORGAN CHASE & CO (31 shares), and GROUP ONE TRADING LLC (12 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.